Evaluation of Taterapox Virus in Small Animals

by Scott Parker, Ryan Crump, Hollyce Hartzler, R. Mark Buller
Published 2017-08-01

Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.

by Isaac G Sakala, Geeta Chaudhri, Preethi Eldi, R Mark Buller, Gunasegaran Karupiah
Published 2015-01-01

Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics

by R. Mark Buller, Jill Schriewer, George Painter, Akbar M. Siddiqui, Scott Parker
Published 2010-09-01

Conventional and Regulatory CD4+ T Cells That Share Identical TCRs Are Derived from Common Clones.

by Kyle J Wolf, Ryan O Emerson, Jeanette Pingel, R Mark Buller, Richard J DiPaolo
Published 2016-01-01

EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence.

by Nicholas van Buuren, Kristin Burles, Jill Schriewer, Ninad Mehta, Scott Parker, R Mark Buller, Michele Barry
Published 2014-08-01

Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.

by Janet J Sei, Scott Haskett, Lauren W Kaminsky, Eugene Lin, Mary E Truckenmiller, Clifford J Bellone, R Mark Buller, Christopher C Norbury
Published 2015-06-01

Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

by Shannon McNulty, William Bornmann, Jill Schriewer, Chas Werner, Scott K Smith, Victoria A Olson, Inger K Damon, R Mark Buller, John Heuser, Daniel Kalman
Published 2010-05-01

Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.

by Susan A Holechek, Karen L Denzler, Michael C Heck, Jill Schriewer, R Mark Buller, Fatema A Legrand, Paulo H Verardi, Leslie A Jones, Tilahun Yilma, Bertram L Jacobs
Published 2013-01-01

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

by Hari Krishna Ananthula, Scott Parker, Erin Touchette, R. Mark Buller, Gopi Patel, Daniel Kalman, Johanna S. Salzer, Nadia Gallardo-Romero, Victoria Olson, Inger K. Damon, Tessa Moir-Savitz, Larry Sallans, Milton H. Werner, Catherine M. Sherwin, Pankaj B. Desai
Published 2018-12-01

Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity.

by Ruth J Napier, Brian A Norris, Alyson Swimm, Cynthia R Giver, Wayne A C Harris, Julie Laval, Brooke A Napier, Gopi Patel, Ryan Crump, Zhenghong Peng, William Bornmann, Bali Pulendran, R Mark Buller, David S Weiss, Rabindra Tirouvanziam, Edmund K Waller, Daniel Kalman
Published 2015-03-01